Posts Tagged ‘healthcare’

« Older Entries
Newer Entries »

OPXA soars, C deals, TSTY turns south

Wednesday, January 5th, 2011

Opexa Therapeutics Inc. (Nasdaq: OPXA) shares leaped 80.8 percent to $2.82. Volume of 3.2 million shares, triumphed over usual volume of 70,317. The Woodlands, Texas-based cell therapy company said that after meeting twice with the U.S. Food and Drug Administration, it is preparing a Phase III clinical study of Tovaxin, a drug intended to treat multiple sclerosis.

Citigroup (NYSE:C) was a volume leader Wednesday, trading in 122,929,357, gaining on a full-day average of 538,020,000. Shares gained 0.7 percent to $4.94.

Tasty Baking Company (Nasdaq: TSTY) shed 33 percent to $4.31, on 159,504, compared to usual volume of below 10,000. TSTY announced today that preliminary financial data indicate the Company did not achieve the expected operational cash savings from this bakery during the fourth quarter.

Tags: , , , , , , ,
Posted in Consumer Discretionary Stocks, Financial Stocks, Health Care Stocks | No Comments »

THLD soars, C sells, ISPH stumbles

Monday, January 3rd, 2011

Threshold Pharmaceuticals Inc. (Nasdaq: THLD) started 2011 higher 34.08 percent in price Monday to $1.81. Volume of 49,432 shares closed in on its all-day average of 94,631. THLD, based in Redwood City, Calif., Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors.

Citigroup Inc. (NYSE: C) did a brisk business the first Monday after New Year, trading in 43,054,072 shares, making up ground on its daily average of 538,216,000. Prices for the stock pushed ahead 1.8 percent to $4.82, on announcing that on New Year’s Eve, C it had completed transactions with Discover Financial Services and SLM Corporation that resulted in the divestiture of its student loan business, The Student Loan Corporation.

Inspire Pharmaceuticals Inc. (Nasdaq: ISPH) listed downward Monday, losing 58.45 percent in price to $3.49, on volume of 6,848,880 shares, dwarfing a full-day average of 577,058. ISPH announced today the top-line results from its second Phase 3 clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis.

Tags: , , , , , , ,
Posted in Financial Stocks, Health Care Stocks | No Comments »

NCT jumps, MGM high volume, NAII dives

Wednesday, December 22nd, 2010

Newcastle Investment Corp. (NYSE: NCT) ended higher 12.89 percent in price Wednesday to $6.92. Volume of 2,363,972 shares proved four times its normal share volume. NCT invests in real estate debt and other real estate related assets.

MGM Resorts International (NYSE: MGM) did a brisk business Wednesday, trading in 36,317,989 shares, nipping its daily average. Prices for MGM dipped, however, 1.07 percent to $14.73. MGM is one of the world’s leading global hospitality companies, operating a peerless portfolio of destination resort brands, including Bellagio, MGM Grand, Mandalay Bay and The Mirage.

Natural Alternatives International Inc. (Nasdaq: NAII) listed downward Wednesday, losing 11.83 percent in price to $5.29, on volume of 539,582 shares, compared to a full-day average of 17,905. NAII, based out of San Marcos, Calif., is a leading formulator, manufacturer and marketer of customized nutritional supplements

Tags: , , , , , , ,
Posted in Consumer Discretionary Stocks, Financial Stocks, Health Care Stocks | No Comments »

BBX takes flight, MU solid, ACUR drubbed

Wednesday, December 22nd, 2010

BankAtlantic Bancorp, Inc. (NYSE: BBX) propelled itself higher 15.24 percent in price Wednesday to $1.21. Volume of 3,957,107 shares was more than six times its daily average, as BBX joined lots of regional banks in popping in price Wednesday.

Micron Technology Inc. (Nasdaq: MU) traded in 31,662,200 shares Wednesday, closing in against its daily average of 33,146,500. Prices for MU inched up 1.6 percent to $8.27. MU was set to announce first fiscal-quarter earnings after the closing bell.

Acura Pharmaceuticals Inc. (Nasdaq: ACUR) took it on the chin Wednesday, losing 12.8 percent in price Wednesday to $3.27, on volume of 410,363 shares, or 11 times its full-day average. ACUR is a specialty pharmaceutical company out of Palatine, Illinois.

Tags: , , , , , ,
Posted in Financial Stocks, Health Care Stocks, Technology Stocks | No Comments »

CNET sings, INTC volume frontrunner, CPIX downward

Wednesday, December 22nd, 2010

ChinaNet Online Holdings Inc. (Nasdaq: CNET) moved higher by 20.79 percent in price Wednesday to $4.30. Volume of 269,526 shares was more than 13 times its daily average. The China-based CNET is a leading full-service B2B media development and internet technology company for small and medium-sized enterprises.

Intel Corp. (Nasdaq: INTC) traded in 32,828,220 shares Wednesday. Although Intel is currently a volume leader, it fell short, in light trading, of its usual volume of 57,889,900. Share prices were down 1% to $220.89.

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) retreated 13.04 percent in price Wednesday to $6.00, on volume of 293,784 shares, compared to a full-day average of 64,679. Nashville-based CPIX announced today that it has received a Complete Response Letter from the FDA regarding its supplemental new drug application (sNDA) for Acetadote® (acetylcysteine) Injection to treat patients with non-acetaminophen induced acute liver failure.

Tags: , , , , , ,
Posted in Health Care Stocks, Technology Stocks | No Comments »

« Older Entries
Newer Entries »